|Mr. Lawrence J. Jasinski||CEO & Director||555.79k||N/A||1957|
|Mr. Ori Gon||Chief Financial Officer||303.42k||N/A||1982|
|Ms. Miri Pariente||VP of Operations, Regulatory & Quality||N/A||N/A||1977|
|Mr. Andy Dolan||VP of Marketing & Reimbursement||N/A||N/A||N/A|
|Ms. Judy Kula||VP of Customer Service, HR & Bus. Affairs||N/A||N/A||N/A|
|Mr. Ami Kraft||Exec. Advisor to the CEO||N/A||N/A||1943|
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes wearable robotic exoskeletons for individuals with mobility impairments or other medical conditions in Israel, the United States, Europe, the Asia-Pacific, Latin America, and Africa. It offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for used in the rehabilitation of individuals with lower limb disability due to stroke; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers, institutions, and individuals, as well as through distributors. The company was formerly known as Argo Medical Technologies Ltd. and changed its name to ReWalk Robotics Ltd. ReWalk Robotics Ltd. was founded in 2001 and is headquartered in Yokneam Ilit, Israel.
ReWalk Robotics Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.